Phosphorus and nutrition in chronic kidney disease

International Journal of Nephrology

Volumn 2012, Issue , 2012, Pages

  González Parra, Emilio ^a   Gracia Iguacel, Carolina ^a   Egido, Jesús ^a   Ortiz, Alberto ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84866151991     PISSN: 2090214X     EISSN: 20902158     Source Type: Journal    
DOI: 10.1155/2012/597605     Document Type: Article

References (45)

1. Hruska K. A., Mathew S., Lund R., Qiu P., Pratt R., Hyperphosphatemia of chronic kidney disease. Kidney International 2008 74 2 148 157 2-s2.0-46249120391 10.1038/ki.2008.130 (Pubitemid 351915080)
2. Isakova T., Gutierrez O. M., Chang Y., Shah A., Tamez H., Smith K., Thadhani R., Wolf M., Phosphorus binders and survival on hemodialysis. Journal of the American Society of Nephrology 2009 20 2 388 396 2-s2.0-59949084660 10.1681/ASN.2008060609
3. Craver L., Marco M. P., Martínez I., Rue M., Borràs M., Martín M. L., Sarró F., Valdivielso J. M., Fernández E., Mineral metabolism parameters throughout chronic kidney disease stages 15achievement of K/DOQI target ranges. Nephrology Dialysis Transplantation 2007 22 4 1171 1176 2-s2.0-34047103452 10.1093/ndt/gfl718 (Pubitemid 46523434)
4. Danziger J., The bone-renal axis in early chronic kidney disease: an emerging paradigm. Nephrology Dialysis Transplantation 2008 23 9 2733 2737 2-s2.0-58549086350 10.1093/ndt/gfn260
5. Takemoto F., Shinki T., Yokoyama K., Gene expression of vitamin D hydroxylase in the remnant kidney of nephrectomized rats. Kidney International 2003 71 31 38 2-s2.0-0037765097
6. Wetmore J. B., Quarles L. D., Calcimimetics or vitamin D analogs for suppressing parathyroid hormone in end-stage renal disease: time for a paradigm shift? Nature Clinical Practice Nephrology 2009 5 1 24 33 2-s2.0-57749208909 10.1038/ncpneph0977
7. Fouque D., Pelletier S., Mafra D., Chauveau P., Nutrition and chronic kidney disease. Kidney International 2011 80 348 357 2-s2.0-79955706020 10.1038/ki.2011.118
8. Levey A. S., Greene T., Beck G. J., Caggiula A. W., Kusek J. W., Hunsicker L. G., Klahr S., Dietary protein restriction and the progression of chronic renal disease: what have all of the results of the MDRD study shown? Modification of diet in renal disease study group. Journal of the American Society of Nephrology 1999 10 11 2426 2439 2-s2.0-0032729501 (Pubitemid 29501478)
9. Fouque D., Laville M., Low protein diets for chronic kidney disease in non diabetic adults. Cochrane Database of Systematic Reviews 2009 3 CD001892 2-s2.0-68549090699
10. Bernhard J., Beaufrère B., Laville M., Fouque D., Adaptive response to a low-protein diet in predialysis chronic renal failure patients. Journal of the American Society of Nephrology 2001 12 6 1249 1254 2-s2.0-17344380806 (Pubitemid 32472639)
11. Shinaberger C. S., Greenland S., Kopple J. D., Van Wyck D., Mehrotra R., Kovesdy C. P., Kalantar-Zadeh K., Is controlling phosphorus by decreasing dietary protein intake beneficial or harmful in persons with chronic kidney disease? The American Journal of Clinical Nutrition 2008 88 6 1511 1518 2-s2.0-57449090292 10.3945/ajcn.2008.26665
12. Lynch K. E., Lynch R., Curhan G. C., Brunelli S. M., Prescribed dietary phosphate restriction and survival among hemodialysis patients. Clinical Journal of the American Society of Nephrology 2011 6 3 620 629 2-s2.0-79952999412 10.2215/CJN.04620510
13. Noori N., Kalantar-Zadeh K., Kovesdy C. P., Bross R., Benner D., Kopple J. D., Association of dietary phosphorus intake and phosphorus to protein ratio with mortality in hemodialysis patients. Clinical Journal of the American Society of Nephrology 2010 5 4 683 692 2-s2.0-77950941643 10.2215/CJN.08601209
14. Food and Nutrition Board, Phosphorus. Dietary Reference Intakes: Calcium, Phosphorus, Magnesium, Vitamin D and Fluoride 1997 Washington, DC, USA edited by Institute of Medicine, National Academy Press 146 189
15. Savica V., Bellinghieri G., Calò L. A., Association of serum phosphorus concentration with cardiovascular risk. American Journal of Kidney Diseases 2009 54 2 389 2-s2.0-67650354695 10.1053/j.ajkd.2009.05.020
16. Fukagawa M., Komaba H., Miyamoto K. I., Source matters: from phosphorus load to bioavailability. Clinical Journal of the American Society of Nephrology 2011 6 2 239 240 2-s2.0-79951891685 10.2215/CJN.11051210
17. Moe S. M., Chen N. X., Seifert M. F., Sinders R. M., Duan D., Chen X., Liang Y., Radcliff J. S., White K. E., Gattone V. H. II, A rat model of chronic kidney disease-mineral bone disorder. Kidney International 2009 75 2 176 184 2-s2.0-58149166886 10.1038/ki.2008.456
18. Moe S. M., Zidehsarai M. P., Chambers M. A., Jackman L. A., Radcliffe J. S., Trevino L. L., Donahue S. E., Asplin J. R., Vegetarian compared with meat dietary protein source and phosphorus homeostasis in chronic kidney disease. Clinical Journal of the American Society of Nephrology 2011 6 2 257 264 2-s2.0-79951895648 10.2215/CJN.05040610
19. Kalantar-Zadeh K., Gutekunst L., Mehrotra R., Kovesdy C. P., Bross R., Shinaberger C. S., Noori N., Hirschberg R., Benner D., Nissenson A. R., Kopple J. D., Understanding sources of dietary phosphorus in the treatment of patients with chronic kidney disease. Clinical Journal of the American Society of Nephrology 2010 5 3 519 530 2-s2.0-77749292030 10.2215/CJN.06080809
20. De Lorenzo A., Noce A., Bigioni M., Calabrese V., Della Rocca D. G., Di Daniele N., Tozzo C., Di Renzo L., The effects of Italian Mediterranean Organic Diet (IMOD) on health status. Current Pharmaceutical Design 2010 16 7 814 824 2-s2.0-77950285223 10.2174/138161210790883561
21. Sullivan C., Sayre S. S., Leon J. B., Machekano R., Love T. E., Porter D., Marbury M., Sehgal A. R., Effect of food additives on hyperphosphatemia among patients with end-stage renal disease: a randomized controlled trial. JAMA 2009 301 6 629 635 2-s2.0-60249096283 10.1001/jama.2009.96
22. Uribarri J., Phosphorus additives in food and their effect in dialysis patients. Clinical Journal of the American Society of Nephrology 2009 4 8 1290 1292 2-s2.0-70349902634 10.2215/CJN.03950609
23. Karalis M., Murphy-Gutekunst L., Patient education. Enhanced foods: hidden phosphorus and sodium in foods commonly eaten. Journal of Renal Nutrition 2006 16 1 79 81 2-s2.0-30644458250 10.1053/j.jrn.2005.11.001 (Pubitemid 43088761)
24. Gutiérrez O. M., Anderson C., Isakova T., Scialla J., Negrea L., Anderson A. H., Bellovich K., Chen J., Robinson N., Ojo A., Lash J., Feldman H. I., Wolf M., CRIC Study Group, Low socioeconomic status associates with higher serum phosphate irrespective of race. Journal of the American Society of Nephrology 2010 21 11 1953 1960 2-s2.0-78149327901 10.1681/ASN.2010020221
25. de Brito-Ashurst I., Varagunam M., Raftery M. J., Yaqoob M. M., Bicarbonate supplementation slows progression of CKD and improves nutritional status. Journal of the American Society of Nephrology 2009 20 9 2075 2084 2-s2.0-69849104461 10.1681/ASN.2008111205
26. Aparicio M., Chauveau P., De Précigout V., Bouchet J. L., Lasseur C., Combe C., Nutrition and outcome on renal replacement therapy of patients with chronic renal failure treated by a supplemented very low protein diet. Journal of the American Society of Nephrology 2000 11 4 708 716 2-s2.0-0034023481 (Pubitemid 30171880)
27. Brunori G., Viola B. F., Parrinello G., De Biase V., Como G., Franco V., Garibotto G., Zubani R., Cancarini G. C., Efficacy and safety of a very-low-protein diet when postponing dialysis in the elderly: a prospective randomized multicenter controlled study. American Journal of Kidney Diseases 2007 49 5 569 580 2-s2.0-34247468432 10.1053/j.ajkd.2007.02.278 (Pubitemid 46667194)
28. Peuchant E., Delmas-Beauvieux M. C., Dubourg L., Thomas M. J., Perromat A., Aparicio M., Clerc M., Combe C., Antioxidant effects of a supplemented very low protein diet in chronic renal failure. Free Radical Biology and Medicine 1997 22 1-2 313 320 2-s2.0-0029962646 10.1016/S0891-5849(96)00282-1 (Pubitemid 26399337)
29. Locatelli F., Alberti D., Graziani G., Buccianti G., Redaelli B., Giangrande A., Prospective, randomised, multicentre trial of effect of protein restriction on progression of chronic renal insufficiency. Northern Italian Cooperative Study Group. The Lancet 1991 337 8753 1299 1304 2-s2.0-0025774283 10.1016/0140-6736(91)92977-A
30. Calò L. A., Savica V., Davis P. A., Phosphate content of beverages in addition to food phoaphate additives:real and insidious danger for renal patients. Journal of Renal Nutrition 2012 22 2 292 293
31. Fouque D., McKenzie J., de Mutsert R., Azar R., Teta D., Plauth M., Cano N., Fouque D., Cano N., Plauth M., Schlawin H., Burnier M., Teta D., Abokasem A., Aladib M., Azar R., Bony C., Broyet C., Chauveau P., Chazot C., Delcroix C., Depuis E., Guy J. P., Hadj El Mrabet A., Heyani A., Nemmar F., Vendrely B., Use of a renal-specific oral supplement by haemodialysis patients with low protein intake does not increase the need for phosphate binders and may prevent a decline in nutritional status and quality of life. Nephrology Dialysis Transplantation 2008 23 9 2902 2910 2-s2.0-58549111403 10.1093/ndt/gfn131
32. Isakova T., Gutiérrez O. M., Chang Y., Shah A., Tamez H., Smith K., Thadhani R., Wolf M., Phosphorus binders and survival on hemodialysis. Journal of the American Society of Nephrology 2009 20 2 388 396 2-s2.0-59949084660 10.1681/ASN.2008060609
33. Gutiérrez O.M., Mannstadt M., Isakova T., Rauh-Hain J. A., Tamez H., Shah A., Smith K., Lee H., Thadhani R., Jüppner H., Wolf M., Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. The New England Journal of Medicine 2008 359 6 584 592 10.1056/NEJMoa0706130
34. Winkelmayer W. C., Liu J., Kestenbaum B., Comparative effectiveness of calcium-containing phosphate binders in incident U.S. dialysis patients. Clinical Journal of the American Society of Nephrology 2011 6 1 175 183 2-s2.0-79251498653 10.2215/CJN.05060610
35. Gonzalez-Parra E., Gonzalez-Casaus M. L., Galán A., Martinez-Calero A., Navas V., Rodriguez M., Ortiz A., Lanthanum carbonate reduces FGF23 in chronic kidney disease Stage 3 patients. Nephrology Dialysis Transplantation 2011 26 8 2567 2571 2-s2.0-79961052017 10.1093/ndt/gfr144
36. Bellinghieri G., Santoro D., Savica V., Emerging drugs for hyperphosphatemia. Expert Opinion on Emerging Drugs 2007 12 3 355 365 2-s2.0-34748918903 10.1517/14728214.12.3.355 (Pubitemid 47518373)
37. Savica V., Calò L. A., Santoro D., Monardo P., Santoro G., Muraca U., Davis P. A., Bellinghieri G., Salivary glands: a new player in phosphorus metabolism. Journal of Renal Nutrition 2011 21 1 39 42 2-s2.0-78650707907 10.1053/j.jrn.2010.11.007
38. Savica V., Calò L. A., Monardo P., Davis P. A., Granata A., Santoro D., Savica R., Musolino R., Comelli M. C., Bellinghieri G., Salivary phosphate-binding chewing gum reduces hyperphosphatemia in dialysis patients. Journal of the American Society of Nephrology 2009 20 3 639 644 2-s2.0-62149116515 10.1681/ASN.2008020130
39. Daugirdas J. T., Finn W. F., Emmett M., Chertow G. M., Frequent Hemodialysis Network Trial Group, The phosphate binder equivalent dose. Seminars in Dialysis 2011 24 1 41 49 2-s2.0-79951799417 10.1111/j.1525-139X.2011.00849.x
40. Delmez J., Block G., Robertson J., Chasan-Taber S., Blair A., Dillon M., Bleyer A. J., A randomized, double-blind, crossover design study of sevelamer hydrochloride and sevelamer carbonate in patients on hemodialysis. Clinical Nephrology 2007 68 6 386 391 2-s2.0-37149001458 (Pubitemid 350258767)
41. Finn W. F., Joy M. S., LAM-308 Study Group, A long-term, open-label extension study on the safety of treatment with lanthanum carbonate, a new phosphate binder, in patients receiving hemodialysis. Current Medical Research and Opinion 2005 21 5 657 664 2-s2.0-18844394253 10.1185/030079905X41453 (Pubitemid 40695287)
42. Chan W. L., Rounsley K., Chapman E., Collings K., Dale C., De Waal S., Patel V., Tanner J., Turner E., Moore J., Borrows R., Lanthanum carbonate is an effective hypophosphatemic agent for hemodialysis patients intolerant of other phosphate binders. Journal of Renal Nutrition 2010 20 4 270 277 2-s2.0-77956646212 10.1053/j.jrn.2009.10.009
43. Evenepoel P., Meijers B. K. I., Bammens B. R. M., Verbeke K., Uremic toxins originating from colonic microbial metabolism. Kidney International 2009 76 supplement 114 S12 S19 2-s2.0-71949106205 10.1038/ki.2009.402
44. Aguilera A., Bajo M. A., Espinoza M., Olveira A., Paiva A. M., Codoceo R., García P., Sánchez S., Celadilla O., Castro M. J., Selgas R., Gastrointestinal and pancreatic function in peritoneal dialysis patients: their relationship with malnutrition and peritoneal membrane abnormalities. American Journal of Kidney Diseases 2003 42 4 787 796 2-s2.0-10744220968 10.1016/S0272-6386(03)00920-X (Pubitemid 37187380)
45. Pierce D., Hossack S., Poole L., Robinson A., Van Heusen H., Martin P., Smyth M., The effect of sevelamer carbonate and lanthanum carbonate on the pharmacokinetics of oral calcitriol. Nephrology Dialysis Transplantation 2011 26 5 1615 1621 2-s2.0-79955638836 10.1093/ndt/gfq598